AngioDynamics (Albany, New York) a provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, said the FDA has granted IDE approval to conduct a clinical study of the NanoKnife System for the ablation of focal prostate cancer. Read More
